Main Conference Day 2 (2nd September 2026) Wednesday, 2 September 2026

08:00 - 09:1575 mins

Breaks & Networking

Registration and Coffee

09:15 - 09:205 mins

Keynote Session: Transforming Biomanufacturing Through Digital Innovation - Part II

Chairperson's Opening Remarks

Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University

09:20 - 09:5535 mins

Keynote Session: Transforming Biomanufacturing Through Digital Innovation - Part II

Keynote Address: AI-Guided Nanoscale Modeling for Accelerated Drug Discovery and Translation

Raye Yeow, Ph.D. - Dean’s Chair Professor, National University of Singapore

09:55 - 10:3035 mins

Keynote Session: Transforming Biomanufacturing Through Digital Innovation - Part II

Keynote Address: Building Next-Generation Digitally Enabled Biomanufacturing Facilities

Makoto Sadamitsu - Head, Drug Substance Technical Transfer & Clinical Manufacturing Execution, Biotherapeutics Process Development, Takeda Pharmaceutical Company Limited

10:30 - 11:0030 mins

Breaks & Networking

Networking Refreshment Break in Exhibit/Poster Hall

11:00 - 11:3030 mins

Building Resilient and Sustainable Bioprocesses: Strategies for the Future of Biomanufacturing

Future-Proof Bioprocessing: Building Climate-Resilient, Target Net-Zero Biopharma Operations Through Data-Driven Design

Yuki Abe, Ph.D. - Director, BioPharm Services Ltd.

11:30 - 12:0030 mins

Building Resilient and Sustainable Bioprocesses: Strategies for the Future of Biomanufacturing

Panel Discussion: Turning Sustainability into Practice: Real-World Strategies for Resilient Bioprocessing

Yuki Abe, Ph.D. - Director, BioPharm Services Ltd.
Makoto Sadamitsu - Head, Drug Substance Technical Transfer & Clinical Manufacturing Execution, Biotherapeutics Process Development, Takeda Pharmaceutical Company Limited

12:00 - 12:3030 mins

Building Resilient and Sustainable Bioprocesses: Strategies for the Future of Biomanufacturing

Scientific Track Presentation

12:30 - 13:5585 mins

Breaks & Networking

Luncheon and Innovation Spotlight: Poster Pitch Showcase

13:55 - 14:005 mins

Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics

Chairperson's Remarks

Chervee Ho - CEO and Co-Founder, BioChromatographix International Pte Ltd

14:00 - 14:3030 mins

Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics

Influence of Nucleic acids on purification and assembly of Virus Like Particles

Lukas Gerstweiler, Ph.D. - Senior Lecturer, Adelaide University

14:30 - 15:0030 mins

Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics

Monoliths, Fibers, and Gigapores - The Next Generation of Chromatography Media for Novel Modalities

Alois Jungbauer - Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences

15:00 - 15:3030 mins

Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics

Purification Strategies for Antibody-Drug Conjugates (ADC): Optimizing Purity with Mixed-Mode Chromatography

Sharon Bola - Global Product Manager, Bio-Rad Laboratories

15:30 - 16:0030 mins

Breaks & Networking

Networking Refreshment Break in Exhibit/Poster Hall

16:00 - 16:3030 mins

Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics

Innovative Downstream Processing for Bi-Specific Antibody

Zhang Wei, Ph.D. - Principal Scientist II, Group Leader, Downstream Processing Group, A*STAR

16:30 - 17:0030 mins

Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics

Engineering and Manufacturing Strategies for Multispecific Antibodies

Tomoyuki Igawa, Ph.D. - Head of Research, Chugai Pharmaceutical Co., Ltd.

17:00 - 17:3030 mins

Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics

Advances in purification of viral vectors, including viruses, virus-like particles, exosomes, and other large vesicles: applications for cell and gene therapy manufacturing.

Scott Wheelwright, Ph.D. - Chairman, CTO & Co-Founder, BioChromatographix International Pte. Ltd. (BCI)

17:30 - 17:355 mins

Breaks & Networking

Close of BPI APAC 2026

* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.